Under the auspices of the NIH, leading experts conduct a detailed examination of any R&D project, thus allowing us access to the brilliant minds of the most experienced and knowledgeable scientists in the world.
A novel and effective investment vehicle aimed at bridging the infamous biotech startup “valley of death” and generating high returns, while furthering the development of medical solutions to a wide variety of unmet needs.
Novel NIH-based Investment Strategy
Based on FreeMind’s data set, empirically shown to yield a high return on investment
FreeMind – Xerion Investments Collaboration
Xerion Investments & FreeMind Group Join Forces on Life Science Principal Investments